Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Abroad (travel likely)RecruitingPHASE4
Conditions
AML (Acute Myeloid Leukemia) · Glioma · Cholangiocarcinoma · Solid Tumor Malignancies
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UCI Irvine Health, Orange, California, United States
New York Presbyterian Hospital-Columbia University Medical Center, New York, New York, United States